StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Alterity Therapeutics's price to sales ratio was 73.6× on Aug 30, 2019, against 193.9× a year earlier. Over the last 3 years it ranged from 64.9× to 367.7×, with a median of 183.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Aug 30, 201973.6×−6.7
2018Dec 31, 201880.4×−188.0
2017Dec 29, 2017268.3×+127.7
2016Dec 30, 2016140.6×–

More Alterity Therapeutics figures

See a number that looks wrong?